BioNTech SE (22UA.F)

EUR 94.05

(4.04%)

Revenue Summary of BioNTech SE

BioNTech SE's latest annual revenue in 2023 was 3.81 Billion EUR , down -77.94% from previous year.
BioNTech SE's latest quarterly revenue in 2024 Q2 was 129.35 Million EUR , down -31.45% from previous quarter.
BioNTech SE reported a annual revenue of 17.31 Billion EUR in annual revenue 2022, down -8.78% from previous year.
BioNTech SE reported a annual revenue of 18.97 Billion EUR in annual revenue 2021, up 3834.42% from previous year.
BioNTech SE reported a quarterly revenue of 188.7 Million EUR for 2024 Q1, down -87.24% from previous quarter.
BioNTech SE reported a quarterly revenue of 167.7 Million EUR for 2023 Q2, down -86.87% from previous quarter.

Annual Revenue Chart of BioNTech SE (2023 - 2017)

Historical Annual Revenue of BioNTech SE (2023 - 2017)

Year	Revenue	Revenue Growth
2023	3.81 Billion EUR	-77.94%
2022	17.31 Billion EUR	-8.78%
2021	18.97 Billion EUR	3834.42%
2020	482.32 Million EUR	344.17%
2019	108.58 Million EUR	-14.88%
2018	127.57 Million EUR	107.11%
2017	61.59 Million EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q2	129.35 Million EUR	-31.45%
2024 Q1	188.7 Million EUR	-87.24%
2023 Q2	167.7 Million EUR	-86.87%
2023 Q4	1.47 Billion EUR	65.2%
2023 FY	3.81 Billion EUR	-77.94%
2023 Q3	895.3 Million EUR	433.87%
2023 Q1	1.27 Billion EUR	-70.15%
2022 Q4	4.27 Billion EUR	23.61%
2022 Q2	3.19 Billion EUR	-49.86%
2022 Q1	6.37 Billion EUR	15.22%
2022 FY	17.31 Billion EUR	-8.78%
2022 Q3	3.46 Billion EUR	8.28%
2021 Q3	6.08 Billion EUR	14.67%
2021 Q1	2.04 Billion EUR	492.98%
2021 Q2	5.3 Billion EUR	159.15%
2021 FY	18.97 Billion EUR	3834.42%
2021 Q4	5.53 Billion EUR	-9.11%
2020 FY	482.32 Million EUR	344.17%
2020 Q4	345.44 Million EUR	412.08%
2020 Q3	67.45 Million EUR	61.53%
2020 Q2	41.76 Million EUR	50.97%
2020 Q1	27.66 Million EUR	-1.16%
2019 Q1	26.15 Million EUR	-58.99%
2019 Q3	28.66 Million EUR	11.16%
2019 Q4	27.98 Million EUR	-2.35%
2019 FY	108.58 Million EUR	-14.88%
2019 Q2	25.78 Million EUR	-1.41%
2018 Q2	21.69 Million EUR	0.0%
2018 Q1	21.69 Million EUR	0.0%
2018 Q3	20.39 Million EUR	-6.0%
2018 Q4	63.77 Million EUR	212.69%
2018 FY	127.57 Million EUR	107.11%
2017 FY	61.59 Million EUR	0.0%

Peer Revenue Comparison of BioNTech SE

Name	Revenue	Revenue Difference
CureVac N.V.	53.75 Million EUR	-7004.059%
Biotest Aktiengesellschaft	684.6 Million EUR	-457.844%
Biotest Aktiengesellschaft	684.6 Million EUR	-457.844%
BRAIN Biotech AG	55.33 Million EUR	-6801.599%
Formycon AG	77.69 Million EUR	-4815.311%
Heidelberg Pharma AG	9.85 Million EUR	-38636.526%
Medigene AG	6.03 Million EUR	-63191.349%